Scientists discover a type of immune cell that produces defensive 'shields' in the skin
A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) led by Dr. Andrés Hidalgo has discovered a ...
BioWorld19h
COVID-19 and Epstein-Barr cause inflammatory shock in children
Multisystem inflammatory syndrome in children (MIS-C), a serious disorder that develops after SARS-CoV-2 infection, could ...
EurekAlert!3d
HKU researchers uncover key mechanisms driving oral cancer spread and highlight potential treatment strategies
A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a ...
TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development
TiumBio (KOSDAQ: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative ...
Scientists identify lncRNA as potential biomarker and therapeutic target for hepatocellular carcinoma
Hepatocellular carcinoma (HCC), the third leading cause of cancer-related deaths worldwide, remains one of the most ...
Yahoo Finance26d
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference
Transforming Growth Factor Beta (TGF-β) is a key immune-suppressive factor in the tumor microenvironment (TME) of most solid tumors, often limiting the efficacy of various immune-oncology therapies.
Keros Therapeutics: Losing Its Lead Drug Is Bad Medicine
Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.
Researchers uncover key mechanisms driving oral cancer spread and highlight potential treatment strategies
A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a breakthrough in understanding the spread of oral squamous cell carcinoma ...